ArticleOPEN ACCESS

The evolving treatment options for diabetic macular edema

International Journal of Inflammation
DOI: 10.1155/2013/689276
16Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults, and diabetic macular edema (DME) is the most common cause of visual impairment in individuals with DR. This review focuses on the pathophysiology, previous treatment paradigms, and emerging treatment options in the management of DME. © 2013 Atul Jain et al.

Cite

CITATION STYLE

APA

Jain, A., Varshney, N., & Smith, C. (2013). The evolving treatment options for diabetic macular edema. International Journal of Inflammation. https://doi.org/10.1155/2013/689276

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free